Søby, S., Prestwich, R., Gyldenkerne, N., Maare, C., Lonkvist, C. K., Andersen, M., Nowicka-Matus, K., Gothelf, A.
, Tramm, T., Toustrup, K., Mihaela, S., Ulahannan, D., Iyizoba-Ebozue, Z.
& Eriksen, J. G. (2025).
Pembrolizumab as first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma: a multi-institutional DAHANCA cohort study.
Acta Oncologica,
64, 1269-1275.
https://doi.org/10.2340/1651-226X.2025.44327
Mondin, A., Barbot, M., Ceccato, F., Pereira, A. M., Angelousi, A., Elenkova, A., Zilaitiene, B., Schalin-Jäntti, C., De Herdt, C., Kanaka-Gantenbein, C., Maiter, D., Gatto, F., Johannsson, G.
, Stochholm, K., Bugalho, M. J., Detomas, M., Reincke, M., Toumba, M., Giordano, R. ... Scaroni, C. (2025).
European survey on metabolic and cardiovascular risk in Cushing syndrome.
Journal of Endocrinological Investigation,
48(11), 2657-2670.
https://doi.org/10.1007/s40618-025-02663-9